Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.3389/fdgth.2024.1378497 | Patient feasibility as a novel approach for integrating IRT and LCA statistical models into patient-centric qualitative data—a pilot study |
| https://doi.org/10.1183/13993003.congress-2024.pa696 | Cost-effectiveness of earlier diagnosis of interstitial lung diseases (ILDs) and treatment of its progressive form, progressive pulmonary fibrosis (PPF) |
| https://doi.org/10.1183/13993003.congress-2024.pa671 | Baseline characteristics of patients enrolled in the FIBRONEER-ILD trial of nerandomilast (BI 1015550) |
| https://doi.org/10.5253/arde.2025.a1 | DNA Identification of a Putative Hybrid Azure Tit × Blue Tit |
| https://doi.org/10.1183/13993003.congress-2025.pa2015 | Improving Pneumococcal Vaccination Coverage in Adults: Results from international case studies |
| https://doi.org/10.1186/s12890-025-03973-7 | Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON) |
| https://doi.org/10.6084/m9.figshare.31054500 | Additional file 2 of Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON) |
| https://doi.org/10.6084/m9.figshare.c.8241132 | Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON) |
| https://doi.org/10.6084/m9.figshare.c.8241132.v1 | Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON) |
| https://doi.org/10.6084/m9.figshare.31054500.v1 | Additional file 2 of Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON) |
| https://doi.org/10.6084/m9.figshare.31054497.v1 | Additional file 1 of Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON) |
| https://doi.org/10.6084/m9.figshare.31054497 | Additional file 1 of Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON) |